Aptorum Group Limited Announces Results of 2020 Annual General Meeting of Shareholders
Regulatory News:
Aptorum Group Limited (Nasdaq: APM; Euronext Paris: APM) (the Company , Aptorum Group or Aptorum ), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced the results of its 2020 annual general meeting of shareholders, which was held on December 9, 2020, in Hong Kong.
At the annual general meeting, the required number of shareholders of the Company:
re-elected all of the Company s current directors, namely Mr. Ian Huen, Mr. Darren Lui, Dr. Clark Cheng, Mr. Charles Bathurst, Dr. Mirko Scherer, Dr. Justin Wu and Professor Douglas Arner as directors of the Company until the Company s next annual general meeting of shareholders or until their respective successors are duly appointed and qualified; and